RETROPHIN, INC. Trademarks
Address: Please login to see owner's address
Entity Type: Corporation
Approximately 10 trademarks found.
BEHIND THE BLUR
Genetic testing for medical purposes; providing information in the field of screening, diagnosis and treatment of Cerebrotendinous Xanthomatosis (CTX)
Current Owner: TRAVERE THERAPEUTICS, INC.
Status: REGISTERED
Filed on: 2020-11-03
IN RARE FOR LIFE
Research and development of pharmaceuticals for the treatment of rare diseases; medical research
Current Owner: TRAVERE THERAPEUTICS, INC.
Status: REGISTERED
Filed on: 2020-09-08
IN RARE FOR LIFE
Pharmaceutical preparations for the prevention of liver diseases and disorders; pharmaceutical preparations for the treatment of liver diseases and...
Current Owner: TRAVERE THERAPEUTICS, INC.
Status: FOURTH EXTENSION - GRANTED
Filed on: 2020-09-08
HALTIGRI
pharmaceutical preparations for the treatment of kidney disease; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis...
Current Owner: TRAVERE THERAPEUTICS, INC.
Status: ABANDONED - NO STATEMENT OF USE FILED
Filed on: 2020-07-24
RENSURVI
pharmaceutical preparations for the treatment of kidney disease; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis...
Current Owner: TRAVERE THERAPEUTICS, INC.
Status: ABANDONED - NO STATEMENT OF USE FILED
Filed on: 2020-07-24
RENKEPI
pharmaceutical preparations for the treatment of kidney disease; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis...
Current Owner: TRAVERE THERAPEUTICS, INC.
Status: ABANDONED - NO STATEMENT OF USE FILED
Filed on: 2020-07-24
SPARKOVI
pharmaceutical preparations for the treatment of kidney disease; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis...
Current Owner: TRAVERE THERAPEUTICS, INC.
Status: ABANDONED - AFTER PUBLICATION
Filed on: 2020-07-24
SPARNEFRI
pharmaceutical preparations for the treatment of kidney disease; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis...
Current Owner: TRAVERE THERAPEUTICS, INC.
Status: ABANDONED - NO STATEMENT OF USE FILED
Filed on: 2020-07-24
CHENODAL
Pharmaceutical preparations containing chenodiol (chenodeoxycholic acid) or derivatives thereof for the treatment of gallstones
Current Owner: TRAVERE THERAPEUTICS, INC.
Status: FIFTH EXTENSION - GRANTED
Filed on: 2020-05-27
